IDO1 and rheumatoid arthritis: With the reduced immunomodulatory ability of SF-MSCs due to a high concentration of inflammatory cytokines, the IDO secretion ability of RA-SF-MSCs, which were exposed to an in vivo RA inflammatory environment for a long time, was lower than that of H-SF-MSCs.